SCHEMBL35212299

SCHEMBL35212299

CC1c2c3cc(Br)c(Cl)c(F)c3nn2[C@@H](C)[C@@H](C)N1C(=O)OC(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34464975 0.85 — —
SCHEMBL35211316 0.82 USP30 (0.32) —
SCHEMBL34465221 0.82 USP30 (0.32) —
SCHEMBL35212331 0.82 USP30 (0.32) —
SCHEMBL34465127 0.82 USP30 (0.32) —
SCHEMBL34466687 0.80 PARP1 (0.33) —
SCHEMBL34466688 0.80 PARP1 (0.33) —
SCHEMBL35212429 0.80 PARP1 (0.33) —
SCHEMBL34465081 0.80 PARP1 (0.33) —
SCHEMBL34464971 0.79 USP30 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260125383-A1 INDAZOLE INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF VENTUS THERAPEUTICS U.S., INC. (US) 2026-05-07 — — US disclosed
Send feedback